BG Medicine is a startup based in the United States, most recent round Acquired, 2 tracked investors.
BG Medicine is a startup founded in 2002 based in the United States. BG Medicine has been acquired. Brouky records 2 investors associated with the company.
BG Medicine develops and markets molecular diagnostic tests for cardiovascular diseases, with its lead product being the FDA-approved Galectin-3® blood test that predicts risk in chronic heart failure patients.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.